Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Orchard Therapeutics plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q2 2023
- Shares held
- 16.6M
- +11.5M (+229.4%) vs. Q2 2023
- Total value
- $46.9M
- +$20.7M (+79.1%) vs. Q2 2023
- New holders
- 3
- 8 more added
- Sold out
- 4
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 47 | $122.0M |
| Q3 2023 | 32 | $46.9M |
| Q2 2023 | 33 | $26.2M |
| Q1 2023 | 35 | $31.2M |
| Q4 2022 | 47 | $16.3M |
| Q3 2022 | 47 | $24.7M |
| Q2 2022 | 50 | $30.2M |
| Q1 2022 | 61 | $38.9M |
| Q4 2021 | 72 | $84.6M |
| Q3 2021 | 79 | $167.4M |
| Q2 2021 | 85 | $350.8M |
| Q1 2021 | 83 | $546.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 2,041,670 | $15.8M | 0.61% | 00.0% | Unchanged |
| CHI Advisors LLC | 12,315,654 | $14.0M | 5.57% | +11,559,916+1,529.6% | Added |
| Federated Hermes, Inc. | 869,327 | $6.72M | 0.02% | +361,105+71.1% | Added |
| Deerfield Management Company, L.P. (Series C) | 316,169 | $2.44M | 0.05% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 248,462 | $1.92M | 0.07% | 00.0% | Unchanged |
| Mariner, LLC | 192,250 | $1.49M | 0.00% | +37,840+24.5% | Added |
| Acadian Asset Management LLC | 120,658 | $936.0K | 0.00% | +399+0.3% | Added |
| Renaissance Technologies LLC | 114,818 | $888.0K | 0.00% | −10,400−8.3% | Reduced |
| Citadel Advisors LLC | 95,272 | $739.3K | 0.00% | −30,249−24.1% | Reduced |
| UBS Oconnor LLC | 71,010 | $551.0K | 0.01% | 00.0% | Unchanged |
| FMR LLC | 41,228 | $319.9K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 31,418 | $242.9K | 0.00% | +3,004+10.6% | Added |
| Cormorant Asset Management, LP | 25,664 | $198.4K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 21,410 | $166.1K | 0.00% | −12,009−35.9% | Reduced |
| Forefront Analytics, LLC | 14,183 | $109.6K | 0.06% | +14,183 | New |
| Susquehanna International Group, LLP | 13,445 | $104.3K | 0.00% | +13,445 | New |
| Morgan Stanley | 11,988 | $92.7K | 0.00% | −14,192−54.2% | Reduced |
| Banque Cantonale Vaudoise | 10,400 | $81.0K | 0.00% | +8,000+333.3% | Added |
| Woodline Partners LP | 10,000 | $77.3K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,352 | $10.4K | 0.00% | +395+41.3% | Added |
| Wells Fargo & Company | 1,250 | $9.66K | 0.00% | −10,000−88.9% | Reduced |
| Global Retirement Partners, LLC | 1,000 | $8.14K | 0.00% | −1,000−50.0% | Reduced |
| UBS Group AG | 380 | $2.94K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 283 | $2.19K | 0.00% | −232−45.0% | Reduced |
| Rhumbline Advisers | 142 | $1.10K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 100 | $1.00K | 0.00% | +30+42.9% | Added |
| CWM, LLC | 83 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 110 | $854 | 0.00% | 00.0% | Unchanged |
| Concord Wealth Partners | 100 | $773 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 12 | $93 | 0.00% | 00.0% | Unchanged |
| Mine & Arao Wealth Creation & Management, LLC. | 10 | $78 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 3 | $23 | 0.00% | +3 | New |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −352,379−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −28,364−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −301−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |